Breaking News Instant updates and real-time market news.

AMTD

TD Ameritrade

06:11
04/09/18
04/09
06:11
04/09/18
06:11

TD Ameritrade upgraded to Buy from Neutral at BofA/Merrill

  • 11

    Apr

  • 12

    Apr

AMTD TD Ameritrade

04/06/18
RSBL
04/06/18
NO CHANGE
RSBL
Buy
TD Ameritrade estimates continue to move higher, says Rosenblatt
Rosenblatt analyst Chris Allen raised TD Ameritrade's Q2 earnings estimate to $76c from 69c, FY18 to $3.13 from $2.99, and FY19 to $4.00 from $3.82 driven by increased trading volumes and higher rates in the near-term. The analyst sees upside to Street Q2 estimates and looking forward, without even factoring in Scottrade revenue synergies and notes Scottrade customers have already begun to explore Ameritrade option capabilities. Allen reiterated his Buy rating on TD Ameritrade and increased his price target to $65 saying he expects accelerating earnings growth, a solid fundamental backdrop, and improving capital returns to drive shares higher.
03/06/18
KBWI
03/06/18
UPGRADE
Target $66.5
KBWI
Outperform
Keefe Bruyette upgrades TD Ameritrade, E-Trade on 'compelling' risk/rewards
Keefe Bruyette analyst Kyle Voigt upgraded shares of both TD Ameritrade (AMTD) and E-Trade (ETFC) to Outperform from Market Perform citing "compelling" risk/reward profiles at current levels. The current backdrop of "strong" economic growth, increasing interest rates, high consumer confidence, and recently, a more normalized level of equity market volatility provides a good operating environment for the e-brokers, Voigt tells investors in a research note. Further, he likes the "downside protection" offered by a potential takeout of E-Trade over the next 12 months. The analyst keeps a $66.50 price target on TD Ameritrade and a $61 price target on E-Trade.
03/06/18
KBWI
03/06/18
UPGRADE
KBWI
Outperform
TD Ameritrade upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette upgraded both TD Ameritrade and E-Trade to Outperform citing valuation and a favorable operating environment.
02/06/18
WELS
02/06/18
NO CHANGE
WELS
Charles Schwab leaving prices unchanged positive for TD Ameritrade, says Wells Fargo
Wells Fargo analyst Christopher Harris says it appears Charles Schwab (SCHW) is not making any material pricing changes. The analyst believes this development is very bullish for TD Ameritrade (AMTD) and E-Trade (ETFC). There is an overhang on the stocks of both companies likely due to fears about incremental price cuts by Charles Schwab, he contends. Harris has an Outperform rating on both TD Ameritrade and E-Trade.

TODAY'S FREE FLY STORIES

INTC

Intel

$53.61

0.08 (0.15%)

06:01
04/19/18
04/19
06:01
04/19/18
06:01
Periodicals
Intel plans to shut down New Devices Group, The Information reports »

Intel plans to shut down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$25.86

0.86 (3.44%)

05:59
04/19/18
04/19
05:59
04/19/18
05:59
Hot Stocks
Adamas Pharmaceuticals announces final results from GOCOVRI Phase 3 study »

Adamas Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

  • 25

    Apr

  • 12

    Jun

TSLA

Tesla

$293.42

5.8 (2.02%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Hot Stocks
Tesla batteries delivering power at 662 locations in Puerto Rico, Musk says »

Tesla CEO Elon Musk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$109.31

-0.9 (-0.82%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Hot Stocks
JPMorgan Chase announces branch expansion in Greater Washington DC »

JPMorgan Chase announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 30

    May

  • 13

    Jul

  • 12

    Oct

ICLK

iClick Interactive Asia

$7.76

0.19 (2.51%)

05:55
04/19/18
04/19
05:55
04/19/18
05:55
Conference/Events
iClick Interactive Asia management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 20

    Apr

SBNY

Signature Bank

$135.08

-1.99 (-1.45%)

05:52
04/19/18
04/19
05:52
04/19/18
05:52
Hot Stocks
Signature Bank reports Q1 EPS ex-items $2.69, consensus $2.67 »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Apr

  • 25

    Apr

SCCO

Southern Copper

$57.33

0.745 (1.32%)

05:50
04/19/18
04/19
05:50
04/19/18
05:50
Downgrade
Southern Copper rating change  »

Southern Copper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

FOXA

21st Century Fox

$37.32

-0.22 (-0.59%)

, DIS

Disney

$101.21

-1 (-0.98%)

05:49
04/19/18
04/19
05:49
04/19/18
05:49
Hot Stocks
21st Century Fox rejected rival bid of $34.41 per share for assets »

Disney (DIS) disclosed…

FOXA

21st Century Fox

$37.32

-0.22 (-0.59%)

DIS

Disney

$101.21

-1 (-0.98%)

CMCSA

Comcast

$33.28

0.02 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 09

    May

NTRS

Northern Trust

$106.38

-0.04 (-0.04%)

05:47
04/19/18
04/19
05:47
04/19/18
05:47
Hot Stocks
Northern Trust enters partnership with The Northern Pool »

The Northern Pool has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$81.72

-0.09 (-0.11%)

, AMGN

Amgen

$175.14

0.19 (0.11%)

05:36
04/19/18
04/19
05:36
04/19/18
05:36
Hot Stocks
Novartis appoints John Tsai as Chief Medical Officer, Head of GDD »

Novartis (NVS) announced…

NVS

Novartis

$81.72

-0.09 (-0.11%)

AMGN

Amgen

$175.14

0.19 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

  • 30

    Apr

  • 17

    May

  • 21

    May

  • 28

    May

  • 05

    Jun

AMZN

Amazon.com

$1,527.24

23.92 (1.59%)

05:36
04/19/18
04/19
05:36
04/19/18
05:36
Recommendations
Amazon.com analyst commentary  »

Amazon online retail…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:34
04/19/18
04/19
05:34
04/19/18
05:34
Earnings
Novartis confirms FY18 revenue guidance of growth of low to mid single-digit »

Novartis noted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:34
04/19/18
04/19
05:34
04/19/18
05:34
Hot Stocks
Novartis reports Q1 Alcon sales of $1.8B »

Alcon net sales were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

RDN

Radian Group

$15.36

-0.91 (-5.59%)

05:30
04/19/18
04/19
05:30
04/19/18
05:30
Recommendations
Radian Group analyst commentary  »

Radian Group price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:29
04/19/18
04/19
05:29
04/19/18
05:29
Hot Stocks
Novartis Q1 results continue to demonstrate benefit from turnaround plan actions »

Novartis noted, Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

05:29
04/19/18
04/19
05:29
04/19/18
05:29
Downgrade
MGIC Investment rating change  »

MGIC Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESNT

Essent Group

$34.83

-2.045 (-5.55%)

, MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

05:28
04/19/18
04/19
05:28
04/19/18
05:28
Downgrade
Essent Group, MGIC Investment, Radian Group rating change  »

Essent Group downgraded…

ESNT

Essent Group

$34.83

-2.045 (-5.55%)

MTG

MGIC Investment

$10.50

-0.275 (-2.55%)

RDN

Radian Group

$15.36

-0.91 (-5.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 04

    May

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:27
04/19/18
04/19
05:27
04/19/18
05:27
Hot Stocks
Novartis reports Q1 Sandoz net sales of $2.5B »

Sandoz net sales were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

NVS

Novartis

$81.72

-0.09 (-0.11%)

05:25
04/19/18
04/19
05:25
04/19/18
05:25
Earnings
Novartis reports Q1 core EPS $1.28, consensus $1.29 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 17

    May

  • 21

    May

  • 05

    Jun

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

, TEVA

Teva

$17.91

0.065 (0.36%)

05:23
04/19/18
04/19
05:23
04/19/18
05:23
Hot Stocks
Procter & Gamble acquires Consumer Health business of Merck KGaA for EUR 3.4B »

Procter & Gamble (PG)…

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

TEVA

Teva

$17.91

0.065 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 27

    Apr

  • 18

    May

  • 05

    Jun

  • 16

    Jun

GOL

GOL Linhas

$13.51

0.72 (5.63%)

05:22
04/19/18
04/19
05:22
04/19/18
05:22
Downgrade
GOL Linhas rating change  »

GOL Linhas downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$78.19

-0.23 (-0.29%)

05:22
04/19/18
04/19
05:22
04/19/18
05:22
Hot Stocks
Breaking Hot Stocks news story on Procter & Gamble »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

  • 27

    Apr

LN

Line Corp.

$38.30

0.09 (0.24%)

05:20
04/19/18
04/19
05:20
04/19/18
05:20
Downgrade
Line Corp. rating change  »

Line Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$177.84

-0.41 (-0.23%)

05:16
04/19/18
04/19
05:16
04/19/18
05:16
Recommendations
Apple analyst commentary  »

Mizuho sees risk to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

SNBR

Sleep Number

$36.58

-0.35 (-0.95%)

05:13
04/19/18
04/19
05:13
04/19/18
05:13
Downgrade
Sleep Number rating change  »

Sleep Number downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.